1. UNIC University of Cuiabá, Centro Cuiabá-MT, Brazil
  2. Universidade do Rio de Janeiro (UNIRIO), Brazil
  3. Institut d’Epidémiologie Neurologique et de Neurologie Tropicale, Limoges, France

E-Mail Contact - SIQUEIRA Heloise Helena : heloise_siqueira (at) hotmail (dot) com


World Health Organization (WHO) estimates 8/1.000 individuals worldwide suffer from epilepsy, and prevalence in developing countries is usually higher than that in developed countries. According to the United Nations Program for Development in the Human Development Report 2013, Brazil ranks 85th in the Human Development Index (HDI) with a course of “high performance” in human development over the past decades, indicating that the country was able to increase the national income and indicators of health and education were recorded as higher than average. This study aimed to describe prevalence of epilepsy in a Brazilian region of Mato Grosso.

A door-to-door survey was conducted in Barra do Bugres in 2011. In phase 1, health agents screened participants using Limoges questionnaire was used to identify patients with epilepsy in tropical regions, and in phase 2, neurological evaluation was performed on the detected cases.

Of the 30,132 subjects who were screened, 305 were deemed positive and were advanced to phase 2 evaluation. Epilepsy was diagnosed in 241 subjects (76 children and 165 adults), prevalence of epilepsy was 7.8/1000 inhabitants, and the overall prevalence rate of active epilepsy was 5.6/1000 inhabitants. In this study, 55.9% were male, 68.7% were afro-descendant ethnicity and 24.4% were illiterates.

The present study is the first conducted in a semiurban region of Brazil using a population survey to evaluate epilepsy prevalence rates. These findings suggested that the association between improvements in health conditions and education are important factors for low epilepsy prevalence rates.

Keywords: Epidemiology, Population survey, Prevalence, Brazil


Epilepsy is a chronic condition and may affect individuals of all ages. It is one of the most common neurological diseases, and affects physical and emotional health of the patient and their families (1). About 70 million individuals worldwide suffer from epilepsy, with 90% of them residing in developing countries (2) and around 2.4 million new cases are estimated to occur annually in developing countries all over the world (3).

Prevalence rate of epilepsy in developing countries is usually higher than that in developed countries (4,5), and this is primarily because of conditions such as neuroinfections, inadequate prenatal care, and complicated childbirth. The prevalence rate of epilepsy has been reported to vary substantially between developed countries (4-7/1000 individuals) and developing countries (5-74/1000 individuals) (2). In a systematic review, median lifetime prevalence rate in Latin American countries is 17.8/1000 individuals (range 6 to 43.2) (6). Epidemiological population survey studies conducted in Brazil, found a wide variability in epilepsy prevalence rate ranging 9.2 to 18.6/1000 individuals (7,8,9,10,11).

Because Brazil is a country with continental proportions and different socioeconomic, cultural, and environmental/climate characteristics for each region, previous studies did not necessarily reflect the reality of the country as a whole. We examined a region that is a rural area of Brazil’s tropical climate and that seemed to be representative of the conditions found in most Brazilian cities. The aim of this study was to determine the prevalence rate of epilepsy in Barra do Bugres using a door-to-door survey.


Study Population and General Design

This study was conducted in Barra do Bugres, which is a semiurban area of the Mato Grosso in Midwest Brazil. The province covers 7,228,902 km2 and has a population of 32,124 individuals. The municipality sanitary conditions can be considered efficient because the Instituto Brasileiro de Geografia e Estatística (IBGE) 2010 (12) has reported that 97.9% of all households are supplied by main water and treated sewage (13) and that only 8.44% of the population over 10 years of age have never attended school (14), indicating that the city has a good literacy rate. The health care infrastructure consists of a municipal hospital and a team of health agents, nurses, and clinics from the Health Family Program (HFP), and it covers more than 75% of the population. Neurologic attendance and electroencephalography examinations have been regular since 2001. Computed tomography scans and magnetic resonance imaging services are available in the region. Ethnically, the population is a mixture of Mestizos, mixed-race descendants of Portuguese colonists and the natives (15). The population may be considered semiurban, and the city’s economy revolves primarily around agriculture or, more specifically, the alcohol industry and cattle.

This study was approved by the ethics committee of the University of Cuiabá. In the first phase of the study, health agents received verbal authorizations from subjects who agreed to participate. All subjects who refused to participate in the first phase, declined to answer a structured questionnaire and therefore were not included in this survey. In the second phase of the study, we had written informed consent from all individuals and / or their guardians under 18 years or cognitive impairment. Each participant received information about the study in question and was well oriented with respect to the neurological treatments that were provided to all identified patients with epilepsy during the study period and for all the time after this research. Collected data was anonymized at all stage of the study.

All households in the period from January 2011 to August 2012 were included. In phase 1, every member of the study population or a proxy respondent who agreed to participate was subjected to a brief screening method (Limoges questionnaire). In phase 2, the presence of epilepsy was confirmed or ruled out in subjects who were screened as positive for that condition in phase 1. Individuals who were screened as negative were not evaluated.

Phase 1: Limoges questionnaire

The Limoges questionnaire was distributed to the subjects at home or at the institution of their current residence by 57 health agents over seven micro areas coordinated by six HFP teams. Only the downtown area lacked a HFP team. All healthcare agents received training and orientations about epilepsy and its clinical manifestations. There were five meetings with presentations of the questionnaire and discussions of each of the items to be asked to the interviewees.

Subjects ≤12-years-old were screened indirectly through an interview with a close relative, usually a parent. The screening instrument used in this survey was the Limoges Questionnaire that was tested and validated in Mauritania (16,17) and was designed to detect epilepsy in tropical regions. There were five questions concerning epilepsy symptoms. All subjects with at least one positive response to any of these five questions were screened as positive for epilepsy and were invited for further evaluation in phase 2.

Phase 2: Clinical diagnosis

Two board-certified neurologists, one of whom was a pediatric neurologist, followed a standardized diagnostic protocol to evaluate all subjects who were screened positive for epilepsy in phase 1. The neurologists interviewed the subjects regarding their personal histories, performed clinical examinations, and reviewed the available laboratory data (electroencephalographic findings and brain imaging findings) to confirm or rule out the diagnoses of epilepsy and to classify the seizures.

Diagnostic Criteria

The guidelines of the International League against Epilepsy (ILAE) (18,19) were adopted as the criteria for the classification of epileptic seizures in the standard protocol. Epilepsy was defined as a condition characterized by two or more unprovoked seizures or seizure episodes. An unprovoked seizure is one without an acute underlying cause. A seizure episode is a cluster of seizures (at least two) that occur within a 24-h period. Different events such as head trauma, stroke, intracranial infection, intoxication, or withdrawal of drugs or alcohol were considered to be acute underlying causes of seizures only when the seizures occurred within 30 days of the event (18). Seizures that occurred more than 30 days after the event were considered to be unprovoked (19) and were accepted in this survey. We excluded subjects who had experienced only a single seizure, subjects who had only experienced neonatal seizures, febrile seizures, or seizures due to an acute underlying cause. The diagnosis of epilepsy was definite if there was a clear description and history of seizures obtained from the subject or relatives or if there was a suggestive description and history of seizures that was corroborated by electroencephalographic findings. The diagnosis was possible if there was a suggestive description and history of seizures without electroencephalographic corroboration (18,19). For both definite and possible cases, epilepsy was considered active if the subject was under antiepileptic medication on the day of evaluation and at least one seizure occurred in five years preceding the day of evaluation or if the subject was not under antiepileptic medication on the day of evaluation and at least 1 seizure occurred in the year preceding the day of evaluation. In all other instances, epilepsy was deemed inactive. For the seizure types reported here, we used the definitions proposed by the Commission on Classification and Terminology of the International League against Epilepsy (18).

Data Analyses

The lifetime prevalence rate was determined when active and inactive epilepsy were considered together (20). Data analyses consisted primarily of simple comparisons of the prevalence rates for various age-sex groups, socioeconomic variables, and the history of concomitant pathologies. Prevalence rates and 95% confidence intervals (CI) were compared for each sex and age group by a Mantel-Haenszel χ2 test. SPSS software version 17.0 was used for statistical analyses. The level of significance was 5% (p < 0.05) as described by Altaman (21).


Of the 32,134 eligible subjects, we screened 30,132 (93.76%) in phase 1. Subjects comprised 15,289 men (50.8%) and 14,843 women (49.2%), of which 21,576 were adults (71.6%) and 8,556 were children (28.4%); individuals less than 15-years-old were considered to be children.

Of the 30,132 subjects, 305 (1%) were deemed positive and were advanced to phase 2 evaluation (Figure 1). However, 2002 subjects who were not screened owing to a lack of consent agreement to participate in this research or because the health workers could not find them at home and uninsured residents for at least two visits were not evaluated further.

In phase 2, 54 non-epileptic cases were identified, and 10 individuals had moved from the city before the neurological assessment.

Epilepsy was diagnosed in 241 subjects (76 children and 165 adults). Active epilepsy was identified in 179 subjects (65 children and 114 adults). Inactive epilepsy was identified in 51 (21.1%), and 11 (4.5%) subjects had only one convulsive episode and therefore were excluded.

The prevalence rate of epilepsy in this study population was 7.8/1000 inhabitants with the overall active epilepsy rate as 5.6/1000, which was bifurcated as 6.0/1000 for men and 5.2/1000 for women, with no statistically significant differences (p > 0.05). Table 1 shows the distribution of gender- and age-based prevalence rates in the study population. The age-specific patterns of prevalence markedly differed between both genders. In the 10-19-year-old group, the age-specific prevalence rate was higher in men than in women (p < 0.05). In contrast, in the 30-39-year-old group, the age-specific prevalence rate was higher in women than in men (p < 0.05), as in Figure 2.

In this study population, 55.9% were male and Afro-descendant ethnicity was reported by 68.7% of the subjects, 4.5% of patients with epilepsy uses septic tanks outside their houses and a total of 22.3% were illiterate. A positive family history for epilepsy in first- and second-degree relatives was observed in 47.5% of the subjects. Figure 3 demonstrates the analysis of the comorbidities among illiterates in sample.

Of the 179 patients with epilepsy, six (3.3%) were diagnosed for the first time during the survey. Seizures could not be classified in four subjects (2.9%). Figure 4 list crisis classification according amount of type of crisis. Of the patients using antiepileptic drugs, 34.6% were under treatment with more than one antiepileptic drug, 90.2% had undergone the electroencephalographic test at least one, 84.2% had undergone a computed tomography study, and 26.9% had undergone magnetic resonance imaging.


The possibility of finding undiagnosed cases is one of the advantages of this kind of study and in this survey we diagnosed six patients (3.3%) with active epilepsy for the first time.

The lifetime prevalence rate of epilepsy in our study population was 7.8/1000 inhabitants, and the overall active epilepsy rate was 5.6/1000 individuals. A systematic review (6) has shown that the median lifetime prevalence rate for all countries in Latin America is 17.8/1000 individuals (range, 6-43.2). When comparing other rural and suburban areas in Latin America, such as Bolivia [epilepsy diagnosed in 12.3/1000 individuals (11.1/1000 for active epilepsy) (22,23), Ecuador epilepsy diagnosed in 14.3/1000 individuals (8.0/1000 for active epilepsy) (24,25), and Uruguay [epilepsy diagnosed in 11.6/1000 individuals (6.4/1000 for active epilepsy) (26,27), the results exhibited remarkably higher prevalence rates. Our data were similar to those reported by Melcon et al. (28) who found a lifetime prevalence rate of 6.2/1000 habitants and an age-adjusted rate of 6.3/1000 individuals. Survey-based studies conducted in Brazil have reported higher prevalence rates, such as 11.9/1000 (10), 16.2/1000 (9), 18.3/1000 (7), and 18.6/1000 (8), in urban and rural areas. We believe that the low prevalence rate of epilepsy in our study population was related to the sanitation in more than 75% of the municipalty, which reduces infections contagious diseases, illiteracy rates, and per capita income above the national average. Furthermore, epilepsy is a complex disease, and its prevalence depends on the interactions of environmental conditions and genetic factors (24).

Automobile accidents are common in urban areas, and poor traffic control, which is associated with a lack of a consistent seat-belt and helmet policy, major contributors to head injury. The prevalence of epilepsy varies according to the severity of the injury (5), however, fast access to neurosurgical services also contribute to the low prevalence rate in our study population. Among the individuals who were illiterates, 75% had a history of associated diseases, such as cognitive impairment due to the Down syndrome or neonatal hypoxic ischemic/cerebral palsy and/or congenital infections, and 2.8% were aged 60 years. The low prevalence rate of epilepsy in our study population may be associated with a number of factors such as low illiteracy rates and adequate sanitary conditions. In fact, Nsengiyumva et al. (29) reported a positive association between epilepsy caused by parasitic disease of the central nervous system after an adjustment for other significant factors, such as sex, poor sanitation, and a past history of severe disease in childhood.


To the best of our knowledge, the present study is the only study conducted in a semiurban region of Brazil using a door-to-door population survey to evaluate epilepsy prevalence rates. The use of health agents as screening instruments was advantageous because they already regularly visit households and teach individuals how to prevent infectious diseases because of contamination and it was easy to educate these professionals regarding the identification of patients with epilepsy. The results of this study suggested that the association between improvements in health conditions and education are important factors contributing to the low epilepsy prevalence rates.

Key Point Box

• This study is the only study conducted in a semiurban region of Brazil using a door-to-door population survey to evaluate epilepsy prevalence rates

• The use of health agents as screening instruments and to teach individuals how to prevent infectious diseases and to educate these professionals regarding the identification of patients with epilepsy

• Our results suggested that the association between improvements in health conditions and education are important factors contributing to the low epilepsy prevalence rates of epilepsy in this region

Competing interests

The authors declare that they have no competing interests.


We would like to thank all those working at the Maracanã Centre for Integrated Healthcare for organizing the reception and booking the patients and the health agents. We would like to thank the Intermunicipal Healthcare Consortium and the Barra do Bugres Municipal Health Department for their support.


  1. World Health Organization [http://www.who.int/mediacentre/factsheets/fs999/es/index.html]
  2. NGUGI AK, BOTTOMLEY C, KLEINSCHMIDT I, SANDER JW, NEWTON CR: Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010, 51:883-90.
  3. MBUBA CK, NGUGI AK, NEWTON CR, CARTER JA: The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008, 49:1491-1503.
  4. Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League against Epilepsy. Epilepsia 1994, 35:89-93.
  5. PREUX PM, DRUET-CABANAC M: Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 2005, 4:21-31.
  6. BURNEO JG, TELLEZ-ZENTENO J, WIEBE S: Understanding the burden of epilepsy in Latin America: A systematic review of its prevalence and incidence. Epilepsy Res 2005, 66:3-74.
  7. BORGES MA, BARROS EP, ZANETTA DMT, BORGES APP: Prevalência da epilepsia entre os índios bakairi do estado do mato grosso, Brasil. Arq Neuropsiquiatr 2001, 60:80-85.
  8. MOACIR ALVES BORGES MA, MIN LL, GUERREIRO CAM, YACUBIAN EMT, CORDEIRO JA, TOGNOLA WA, BORGES APP, ZANETTA DMT: Urban prevalence of epilepsy. Populational study in São José do Rio Preto, a medium-sized city in Brazil. Arq Neuropsiquiatr 2004, 62:199-204.
  9. GOMES MM, ZEITOUNE GR, KROPF LAL, VAN BEECK ES: A house-to-house survey of epileptic seizures in an urban community of Rio de Janeiro, Brazil. Arq Neuropsiquiatr 2002, 60:708-711.
  10. MARINO JR R, CUKIERT A, PINHO E: Aspectos epidemiológicos da epilepsia em São Paulo. Um estudo da prevalência. Arq Neuropsiquiatr 1986, 44:243-254.
  11. NORONHA ALA, BORGES MA, MARQUES LHN, ZANETTA DMT, FERNANDES PT, BOER H, ESPÍNDOLA J, MIRANDA CT, PRILIPKO L, BELL GS, SANDER JW, LI LM: Prevalence and Pattern of Epilepsy Treatment in Different Socioeconomic Classes in Brazil. Epilepsia 2007, 48:880-885.
  12. IBGE [http://cidades.ibge.gov.br/xtras/temas.php?codmun=510170&idtema=76&search=mato-grosso|barra-do-bugres|censo-demografico-2010:-cnefe-cadastro-nacional-de-enderecos-para-fins-estatisticos]
  13. IBGE [http://cidades.ibge.gov.br/xtras/temas.php?lang=&codmun=510170&idtema=105&search=mato-grosso|barra-do-bugres|censo-demografico-2010:-resultados-da-amostra-educacao]
  14. IBGE [http://www.ibge.gov.br/cidadesat/xtras/temas.php?codmun=510170&idtema=20&search=mato-grosso|barra-do-bugres|pesquisa-nacional-de-saneamento-basico-2008]
  15. IBGE [http://cidades.ibge.gov.br/painel/historico.php?lang=&codmun=510170&search=mato-grosso|barra-do-bugres|infograficos:-historico]
  16. PREUX PM: Questionnaire in a study of epilepsy in tropical countries. Bull Soc Pathol Exot 2000, 93:276-278.
  17. DIAGANA M, PREUX PM, TUILLAS M, OULD HAMADY A, DRUET-CABANAC M: Dépistage de l’épilepsie en zones tropicales: validation d’un questionnaire en Mauritanie. Bull Soc Pathol Exot 2006, 99:103-107. [Article in French].
  18. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Commission on Classification and Terminology of the International League against Epilepsy. Epilepsia 1981, 22:489-501.
  19. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League against Epilepsy. Epilepsia 1989, 30:389-399.
  20. ROCCA WA, SAVETTIERI G, ANDERSON DW, MENEGHINI F, GRIGOLETTO F, MORGANTE L, REGGIO A, SALEMI G, PATTI F, DI PERRI R: Door-to-door prevalence survey of epilepsy in three Sicilian municipalities. Neuroepidemiology 2001, 20:237-241.
  21. LAST JM, ABRAMSON JH, FRIEDMAN GD, PORTA M, SPASOFF RA, THURIAUX M: A Dictionary of Epidemiology, ed 3. New York: Oxford University Press; 1995.
  22. ALTMAN DG: Practical statistics for medical research. London: Chapman & Hall; 1991.
  23. NICOLETTI A, REGGIO A, BARTOLONI A, FAILLA G, BARTALESI F, ROSELLI M, GAMBOA H, SALAZAR E, PARADISI F, TEMPERA G, HALL A: A neuroepidemiological survey in rural Bolivia: background and methods. Neuroepidemiology 1998, 17:273-280.
  24. NICOLETTI A, REGGIO A, BARTOLONI A, FAILLA G, SOFIA V, BARTALESI F, ROSELLI M, GAMBOA H, SALAZAR E, OSINAGA R, PARADISI F, TEMPERA G, DUMAS M, HALL AJ: Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology 1999, 53:2064-2069
  25. PLACENCIA M, SUAREZ J, CRESPO F, SANDER JWAS, SHORVON SD, ELLISON RH, CASCANTE SM: A large-scale study of epilepsy in Ecuador: methodological aspects. Neuroepidemiology 1992, 11:74-84.
  26. PLACENCIA M, SHORVON SD, PAREDES V, BIMOS C, SANDER JWAS, SUAREZ J, CASCANTE SM: Epileptic seizures in an Andean region of Ecuador: incidence and prevalence and regional variation. Brain 1992, 115:771-782.
  27. SCARAMELLI A, KETZOIAN C, CASERES R, DIEGUEZ E, COIROLO G, REGA I, CHOUZA C: Prevalence of epilepsies in a population of Uruguay: study of Villa del Cerro. J Neurol Sci 1997, 150:S29.
  28. MELCON MO, KOCHEN S, VERGARA RH: Prevalence and Clinical Features of Epilepsy in Argentina. A Community-Based Study. Neuroepidemiology 2007, 28:8-15.
  29. NSENGIYUMVA G, DRUET-CABANAC M, RAMANANKANDRASANA B, BOUTEILLE B, NSIZABIRA L, PREUX PM: Cysticercosis as a major risk factor towards epilepsy in Burundi, East Afric

© 2002-2012 African Journal of Neurological Sciences.
All rights reserved. Terms of use.
Tous droits réservés. Termes d'Utilisation.
ISSN: 1992-2647